Hélène Pillant

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

Édouard Louis, Jean–Yves Mary, Gwénola Vernier-Massouille et al. · Gastroenterology · 2011 · 589 citations · Full text

Inflammation, Antimetabolite Therapy, Anti-inflammatory +5

Alterations in the Intestinal Microbiome (Dysbiosis) as a Predictor of Relapse After Infliximab Withdrawal in Crohnʼs Disease

Sylvie Rajca, Virginie Grondin, Édouard Louis et al. · Inflammatory Bowel Diseases · 2014 · 234 citations · Full text

961 Infliximab Discontinuation in Crohn's Disease Patients in Stable Remission On Combined Therapy with Immunosuppressors: A Prospective Ongoing Cohort Study

Édouard Louis, Gwénola Vernier-Massouille, Jean–Charles Grimaud et al. · Gastroenterology · 2009 · 55 citations

Inflammation, Autoimmune Disease, Immunology +10

Psychometric properties of a questionnaire (HEMO‐FISS‐QoL) to evaluate the burden associated with haemorrhoidal disease and anal fissures

Laurent Abramowitz, D. Bouchard, Laurent Siproudhis et al. · Colorectal Disease · 2018 · 46 citations · Full text

P274 Close monitoring of CRP and fecal calprotectin levels to predict relapse in Crohn's disease patients. A sub-analysis of the STORI study

N de Suray, Julia Salleron, G. Vernier‐Massouille et al. · Journal of Crohn s and Colitis · 2012 · 34 citations

Inflammation, Stori Study, P274 Close Monitoring +7